Welcome to CSNpharm! For Research Use Only!

Myosin light-chain kinase also known as MYLK or MLCK is a serine/threonine-specific protein kinase that phosphorylates a specific myosin light chain, namely, the regulatory light chain of myosin II.


Cat. No. Product Name CAS No. Information
CSN22980 MLCK inhibitor peptide 18 224579-74-2 MLCK Inhibitor Peptide 18 is a selective competitive inhibitor of myosin light chain kinase with IC50 of 50 nM.
CSN12294 ML-7 hydrochloride   110448-33-4 ML-7 HCl is a multiple-target inhibitor of MLCK with Ki value of 300 nM PKA with 21M and PKC of 42 M
CSN23710 ML-9 105637-50-1 ML 9 a is myosin light chain kinase (MLCK) inhibitor. ML-9 enhances the anticancer activity of docetaxel, suggesting its potential application as an adjuvant to existing anticancer chemotherapy. The complex effect of ML-9 on autophagy and indentified ML-9 as an attractive tool for targeting autophagy in cancer therapy through dual inhibition of both the Akt pathway and the autophagy.
CSN26207 HA-100 84468-24-6 HA-100 is an inhibitor of cGMP-dependent protein kinase (PKG), cAMP-dependent protein kinase (PKA), protein kinase C (PKC) and MLC-kinase (IC50 values are 4, 8, 12 and 240 μM, respectively).
CSN10984 Fasudil Hydrochloride   105628-07-7 Fasudil HCl is a potent inhibitor of ROCK-II, PKA, PKG, PKC, and MLCK with Ki of 0.33 μM, 1.6 μM, 1.6 μM, 3.3 μM and 36 μM, respectively.
CSN33153 W-7 hydrochloride 61714-27-0 Calmodulin antagonist. Inhibits myosin light chain kinase
<< PREV 1 NEXT >>